/PRNewswire/ LifeArc Ventures, the investment arm of LifeArc, today announced its participation in a USD $16 million (GBP £13 million) Series A financing.
AviadoBio, a pioneering, pre-clinical stage gene therapy company focused on developing and delivering transformative medicines for people with neurodegenerative disorders, today announced the appointment